135 related articles for article (PubMed ID: 32417395)
1. IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway.
Yang YF; Wang YY; Hsiao M; Lo S; Chang YC; Jan YH; Lai TC; Lee YC; Hsieh YC; Yuan SF
Cancer Lett; 2020 Aug; 485():27-37. PubMed ID: 32417395
[TBL] [Abstract][Full Text] [Related]
2. TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3β signaling.
He K; Guo X; Liu Y; Li J; Hu Y; Wang D; Song J
Cell Mol Life Sci; 2016 May; 73(10):2105-21. PubMed ID: 26781467
[TBL] [Abstract][Full Text] [Related]
3. Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis.
Bajaj R; Rodriguez BL; Russell WK; Warner AN; Diao L; Wang J; Raso MG; Lu W; Khan K; Solis LS; Batra H; Tang X; Fradette JF; Kundu ST; Gibbons DL
Cell Rep; 2022 Sep; 40(13):111429. PubMed ID: 36170810
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction induces the invasive phenotype, and cell migration and invasion, through the induction of AKT and AMPK pathways in lung cancer cells.
Han SY; Jeong YJ; Choi Y; Hwang SK; Bae YS; Chang YC
Int J Mol Med; 2018 Sep; 42(3):1644-1652. PubMed ID: 29916527
[TBL] [Abstract][Full Text] [Related]
5. IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
Bajaj R; Kundu ST; Grzeskowiak CL; Fradette JJ; Scott KL; Creighton CJ; Gibbons DL
Oncogene; 2020 Sep; 39(37):5979-5994. PubMed ID: 32753652
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway.
Kung-Chun Chiu D; Pui-Wah Tse A; Law CT; Ming-Jing Xu I; Lee D; Chen M; Kit-Ho Lai R; Wai-Hin Yuen V; Wing-Sum Cheu J; Wai-Hung Ho D; Wong CM; Zhang H; Oi-Lin Ng I; Chak-Lui Wong C
Cell Death Dis; 2019 Dec; 10(12):934. PubMed ID: 31819034
[TBL] [Abstract][Full Text] [Related]
7. NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.
Xu J; Chi F; Guo T; Punj V; Lee WN; French SW; Tsukamoto H
J Clin Invest; 2015 Apr; 125(4):1579-90. PubMed ID: 25798621
[TBL] [Abstract][Full Text] [Related]
8. Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.
Tsuru A; Setoguchi T; Matsunoshita Y; Nagao-Kitamoto H; Nagano S; Yokouchi M; Maeda S; Ishidou Y; Yamamoto T; Komiya S
Br J Cancer; 2015 Mar; 112(7):1232-40. PubMed ID: 25742474
[TBL] [Abstract][Full Text] [Related]
9. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.
Hsu YL; Wu CY; Hung JY; Lin YS; Huang MS; Kuo PL
Carcinogenesis; 2013 Jun; 34(6):1370-81. PubMed ID: 23389289
[TBL] [Abstract][Full Text] [Related]
10. MCU-dependent mitochondrial Ca
Ren T; Zhang H; Wang J; Zhu J; Jin M; Wu Y; Guo X; Ji L; Huang Q; Zhang H; Yang H; Xing J
Oncogene; 2017 Oct; 36(42):5897-5909. PubMed ID: 28650465
[TBL] [Abstract][Full Text] [Related]
11. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
12. A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells.
Mori K; Uchida T; Yoshie T; Mizote Y; Ishikawa F; Katsuyama M; Shibanuma M
FEBS J; 2019 Feb; 286(3):459-478. PubMed ID: 30281903
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis.
Kuo CL; Chou HY; Chiu YC; Cheng AN; Fan CC; Chang YN; Chen CH; Jiang SS; Chen NJ; Lee AY
Cancer Lett; 2020 Apr; 474():138-150. PubMed ID: 31987921
[TBL] [Abstract][Full Text] [Related]
14. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
15. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
[TBL] [Abstract][Full Text] [Related]
16. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C
Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects.
Ashrafizadeh M; Mirzaei S; Hushmandi K; Rahmanian V; Zabolian A; Raei M; Farahani MV; Goharrizi MASB; Khan H; Zarrabi A; Samarghandian S
Life Sci; 2021 Aug; 278():119649. PubMed ID: 34043989
[TBL] [Abstract][Full Text] [Related]
19. Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway.
Zheng Q; Zhao Y; Guo J; Zhao S; Fei C; Xiao C; Wu D; Wu L; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):515. PubMed ID: 29725013
[TBL] [Abstract][Full Text] [Related]
20. Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming.
Feng S; Zhang L; Liu X; Li G; Zhang B; Wang Z; Zhang H; Ma H
J Cell Mol Med; 2020 Jul; 24(14):7789-7801. PubMed ID: 32519437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
